Medico Remedies share price
NSE: MEDICOBSE: 540937Pharmaceuticals & BiotechnologySmall Cap
Last close ₹19.90down ₹0.60 (2.93%)BSE ₹20.17
Share price at the NSE close on 23 Oct 2026. Previous close ₹20.50.
52-week range of traded prices to 23 Oct 2026
₹19.11Low, 23 Oct 2026₹56.88High, 24 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹165 Cr2,034th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 12.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 May 2026
- 2.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 20.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 15.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 May 2026
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,57,78351.0% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹69 Crup 22.17%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2.52 Crdown 57.01%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 3.6%
Revenue by year
Peak revenue ₹206 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 12 Nov | Dec 2024Filed 5 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 8 Aug | Sep 2025Filed 14 Nov | Dec 2025Filed 13 Apr | Mar 2026Filed 21 May | Jun 2026Filed 13 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.3 | 39.5 | 41.3 | 38.3 | 52.6 | 58.7 | 56.8 | 69.4 |
| Net profit | 1.6 | 2.6 | 4.3 | 1.8 | 2.6 | 2.9 | 5.9 | 2.5 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 3.9% | 6.6% | 10.5% | 4.8% | 4.9% | 4.9% | 10.3% | 3.6% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, manufacturer and exporter of pharmaceutical formulations, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 0.1% of 1,015 trading days over the last 5 years.
LowestHighest
Its median43.0Industry median28.3
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 0.1% of 1,008 trading days over the last 5 years.
LowestHighest
Its median6.7Industry median2.9
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.10.4
At or below today's level on 0.1% of 744 trading days over the last 3 years.
LowestHighest
Its median28.2Industry median18.7
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −36.5% | +29.5% | −50.9% | 0.0% |
| 3 years | −24.1% | +22.0% | −37.8% | 0.0% |
Longer windows are left empty: a corporate action or price step on 2021-11-17 that cannot be sized sits inside this window.
Mutual funds holding it
2 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before.
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
| Fund | |||
|---|---|---|---|
 Motilal Oswal BSE Healthcare ETFMotilal Oswal Mutual Fund | 902 | – | ₹19,000 |
 Bandhan BSE Healthcare Index FundBandhan Mutual Fund | 425 | – | ₹9,000 |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Medico Remedies in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Brooks LaboratoriesBROOKS | 170 | 12.9 | 1.4 | 29.4 | −7.7% | +550.4% | 12.0% | 3.2% | 0.00% |
 Oxygenta PharmaceuticalOXYGENTAPH | 170 | – | – | – | +20.6% | – | – | −15.1% | 0.00% |
 Achyut HealthcareACHYUT | 168 | – | – | – | – | – | – | – | 0.00% |
 Syschem (India)SYSCHEM | 166 | – | – | – | +59.1% | – | – | 11.7% | 0.00% |
 Smruthi OrganicsSMRUTHIORG | 153 | 20.7 | 2.1 | 8.5 | −4.6% | +118.2% | 10.2% | 14.8% | 1.12% |
 Natural CapsulesNATCAPSUQ | 149 | – | 0.7 | – | +8.8% | – | −9.5% | −5.2% | 0.00% |
 Curis LifesciencesCURIS | 143 | 20.6 | 3.0 | 14.5 | – | – | 14.6% | 15.1% | 0.00% |
 Kimia BiosciencesKIMIABL | 142 | 19.7 | 8.0 | 12.5 | −6.7% | −18.2% | 51.9% | 19.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
29 Sep · Legal
The exchange asked on 29 Sep 2026
Aug 2026
29 Aug · General Updates
17 Aug · Legal
Medico Remedies share price by year
Each calendar year to 2025.Medico Remedies share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 50.60 | −7.9% | 78.08 | 38.19 |
| 2024 | 54.95 | −34.4% | 90.65 | 35.65 |
| 2023 | 83.80 | +28.6% | 96.70 | 60.89 |
| 2022BSE close | 65.17 | +181.6% | 65.88 | 15.44 |
| 2021BSE close | 23.14 | – | 29.87 | 23.14 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 17 Nov 2021.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 20.55 | 20.64 | 19.11 | 19.90 | 19.76 | 1,57,783 | 51.0% |
| 22 Oct 2026 | 20.97 | 20.97 | 20.30 | 20.50 | 20.59 | 64,951 | 55.7% |
| 21 Oct 2026 | 21.80 | 22.00 | 20.62 | 20.78 | 21.02 | 1,36,099 | 66.6% |
| 19 Oct 2026 | 22.04 | 22.45 | 21.14 | 21.43 | 21.47 | 2,02,900 | 79.0% |
| 16 Oct 2026 | 22.30 | 22.30 | 21.75 | 22.03 | 21.97 | 1,54,707 | 74.2% |
| 15 Oct 2026 | 22.20 | 22.45 | 21.80 | 21.91 | 22.15 | 1,54,699 | 59.8% |
| 14 Oct 2026 | 22.76 | 22.85 | 21.25 | 21.85 | 22.17 | 1,56,677 | 54.6% |
| 13 Oct 2026 | 22.25 | 22.67 | 21.90 | 22.50 | 22.23 | 95,928 | 57.5% |
| 12 Oct 2026 | 22.92 | 23.54 | 21.90 | 22.15 | 22.49 | 3,16,853 | 55.3% |
| 9 Oct 2026 | 22.20 | 23.15 | 21.00 | 22.80 | 22.16 | 3,09,864 | 55.1% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 25 Sep 2026 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for. |
| 27 Feb 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 16 Mar 2023 | Split | 0.2000 | Each share became 5. |
| 17 Nov 2021 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- Legal name
- Medico Remedies Limited
- NSE symbol
- MEDICO
- BSE code
- 540937
- ISIN
- INE630Y01024
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Feb 2018 on BSE, May 2022 on NSE
- Face value
- ₹2
- CIN
- L24230MH1994PLC077187
- Corporate identity number, the registrar of companies' code for it